Dermapharm Holding SE Strategic Asset Allocation Index
Dermapharm Holding SE strategic asset allocation index. Dermapharm Holding SE (DMP) has a Strategic Asset Allocation Index of 45.4% as of December 2025. Strategic assets (PP&E of €318.54 Million plus long-term investments of €-) total €318.54 Million, measured against net assets of €701.83 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See net asset quality index of Dermapharm Holding SE to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
Strategic Asset Allocation Index of Dermapharm Holding SE (2014–2025)
Strategic asset allocation index of Dermapharm Holding SE from 2014 to 2025. This chart shows how Dermapharm Holding SE's Strategic Asset Allocation Index has evolved across 12 annual periods from 2014 to 2025. As of December 2025, the index stands at 45.4%, representing strategic assets of €318.54 Million against net assets of €701.83 Million EUR. Check DMP tangible net assets ratio to evaluate the tangible quality of the company's equity base.
Dermapharm Holding SE Strategic Asset Allocation Index by Year (2014–2025)
Dermapharm Holding SE strategic asset allocation index by year from 2014 to 2025. The table below presents the year-by-year Strategic Asset Allocation Index for Dermapharm Holding SE from 2014 to 2025, covering 12 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see DMP market cap.
| Year | SAAI | Strategic Assets (EUR) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 45.4% | €318.54 Million | €318.54 Million | €- | €701.83 Million | ▼ -6.4 pp |
| 2024 | 51.8% | €315.03 Million | €315.03 Million | €- | €608.29 Million | ▼ -8.9 pp |
| 2023 | 60.7% | €330.77 Million | €330.77 Million | €- | €545.05 Million | ▲ +18.3 pp |
| 2022 | 42.4% | €225.67 Million | €225.67 Million | €- | €532.49 Million | ▼ -2.1 pp |
| 2021 | 44.5% | €222.29 Million | €222.29 Million | €- | €499.83 Million | ▼ -17.0 pp |
| 2020 | 61.5% | €199.62 Million | €199.62 Million | €- | €324.58 Million | ▲ +14.9 pp |
| 2019 | 46.6% | €132.59 Million | €132.59 Million | €- | €284.49 Million | ▲ +13.1 pp |
| 2018 | 33.5% | €85.73 Million | €80.87 Million | €4.85 Million | €256.08 Million | ▼ -47.7 pp |
| 2017 | 81.2% | €59.84 Million | €56.04 Million | €3.80 Million | €73.69 Million | ▼ -12.4 pp |
| 2016 | 93.6% | €56.91 Million | €53.36 Million | €3.56 Million | €60.81 Million | ▼ -63.0 pp |
| 2015 | 156.6% | €69.60 Million | €53.41 Million | €16.19 Million | €44.44 Million | ▼ -41.6 pp |
| 2014 | 198.2% | €67.42 Million | €56.55 Million | €10.87 Million | €34.01 Million | — |